Greenwich Lifesciences Inc (GLSI) — Financial Flexibility Index
Greenwich Lifesciences Inc (GLSI) has a Financial Flexibility Index of -0.90x as of March 2026. Free cash flow of $-4.70 Million (operating CF $-4.70 Million minus capex $3.00) represents -1% of total liabilities ($5.24 Million). Check total reinvestment intensity of Greenwich Lifesciences Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Greenwich Lifesciences Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Greenwich Lifesciences Inc across 9 annual periods. For the full cash flow conversion analysis, see GLSI cash flow metrics.
Annual Financial Flexibility Index for Greenwich Lifesciences Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Greenwich Lifesciences Inc. Explore Greenwich Lifesciences Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.70x | $-9.91 Million | $-9.91 Million | $5.82 Million | ▲ +63.5% |
| 2024 | -4.66x | $-7.27 Million | $-7.27 Million | $1.56 Million | ▲ +78.8% |
| 2023 | -22.01x | $-6.48 Million | $-6.48 Million | $294.41K | ▲ +6.7% |
| 2022 | -23.58x | $-6.20 Million | $-6.20 Million | $262.90K | ▼ -111.7% |
| 2021 | -11.14x | $-4.29 Million | $-4.29 Million | $385.17K | ▼ -910.3% |
| 2020 | -1.10x | $-1.15 Million | $-1.15 Million | $1.05 Million | ▼ -417.8% |
| 2019 | -0.21x | $-293.27K | $-293.27K | $1.38 Million | ▼ -1795.0% |
| 2018 | -0.01x | $-114.95K | $-114.95K | $10.23 Million | ▲ +20.4% |
| 2017 | -0.01x | $-120.85K | $-120.85K | $8.56 Million | — |